Vinge advises Finanzero Brazil in connection with capital raising

Vinge advises Finanzero in connection with the company's capital raising of approximately SEK 100 million by way of a directed share issue.

Vinge advises Cantargia on directed share issue

Cantargia AB (publ) makes a directed share issue of approximately SEK 106 million to a number of Nordic institutional and private investors.

Vinge advises CGI on its offer for Acando

CGI Inc. has announced a recommended cash offer to the shareholders of Acando AB (publ) to tender all their shares in Acando to CGI.

Vinge advises Vostok New Ventures Ltd

Vinge has advised Vostok New Ventures Ltd with capital markets related questions in light of the company’s divestment of its portfolio asset Avito, for in total USD 540 million, equivalent of approximately SEK 4,842 million, as well as in connection with the subsequent split and mandatory redemption program whereby each depository receipt holder (“SDRs”) will receive a cash consideration of SEK 25 per SDR.

Vinge advised Strax on an automatic redemption procedure

Vinge has advised Strax AB in connection with an automatic redemption procedure according to which each outstanding share in Strax has been split into two shares, of which one share (called redemption share) has been redeemed for a proceed of SEK 1.10.

Vinge advises Oncopeptides in connection with a directed share issue

The board of directors of Oncopeptides has resolved on a directed new issue of shares, whereby Oncopeptides will raise proceeds of approximately SEK 546 million, before issue costs.

Vinge has advised Cavotec SA in connection with rights issue

Cavotec SA (Nasdaq Stockholm) has completed a rights issue of shares, whereby Cavotec SA raised proceeds of MSEK 204, before issue costs.

Vinge advises Fagerhult

AB Fagerhult (publ) has entered into an agreement to acquire iGuzzini illuminazione S.p.A. for EUR 385 million on a cash and debt free basis.

Vinge advises in connection with the sale of preference shares in Volvo Cars

Vinge has advised the Första AP fonden in connection with the sale of all of Första AP fonden’s preference shares in Volvo Cars.

Vinge is advising Danica Pension, Livsforsikringsaktieselskab, part of Danske Bank Group, in connection with the sale of all of shares in Danske Pension Försäkringsaktiebolag (publ).

Danica Pension Försäkringsaktiebolag (publ) has approx. 60 employees, 150,000 personal customers and 15,000 business customers.

Vinge advises Azelio in connection with its capital raising and listing on Nasdaq First North

Vinge has advised Azelio AB (publ) (“Azelio”) in connection with its capital raising and listing on Nasdaq First North.

Vinge advises Xspray Pharma in connection with a directed share issue

The board of directors of Xspray Pharma AB (publ) has resolved on a directed new issue of shares, whereby Xspray Pharma will raise proceeds of approximately SEK 92 million, before issue costs. 

Vinge advises Biotage in connection with its acquisition of PhyNexus

Vinge advises Biotage AB (publ) (“Biotage”), listed on Nasdaq Stockholm, in connection with its acquisition of PhyNexus, Inc. (“PhyNexus”), financed through a combination of newly issued shares and existing cash at hand.

Vinge assists Stendörren in connection with EQT Real Estate II’s cash offer to the shareholders in Stendörren

Vinge has assisted Stendörren Fastigheter AB (publ) (“Stendörren”) in connection with EQT Real Estate II’s, through Chicago Holding AB (“Chicago Holding”), cash offer to the shareholders in Stendörren.

Vinge advises Vicore Pharma in connection with a directed share issue

The board of directors of Vicore Pharma has resolved, subject to the approval by an extraordinary general meeting, on a directed new issue of shares, whereby Vicore Pharma will raise proceeds of approximately SEK 160 million before issue costs.